Press release
Epilepsy Drugs Market 2017- UCB, EISAI, Pfizer
Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing healthcare costs as part of government austerity measures, particularly in Europe and low accessibility to antiepileptic drugs in low and middle income countries, are likely to restrict the market growth.
Get sample report @ https://goo.gl/HPfrnn
Top companies which cover in this report
1. UCB
2. EISAI
3. Pfizer
4. Sanofi
5. Lundbeck
Vimpat is the undisputed leading drug of Global Epilepsy Drugs Market. It has a market share of nearly 22% in 2016 and is expected that Vimpat will gain its momentum till the forecasting period. Keppra was the second highest market share taker with more than 19% share in 2016 but the prospect of this drug will change due to the patent expiration in 2018 and its share decline to XX% by 2021. It is expected that Lamictal will be second leading drug with nearly XX% share by 2021. Onfi hold the third highest share of the Epilepsy Drugs market, being followed by Depakine by the year end of 2021.
The research report titled “Epilepsy Drugs Market: Global Demand, Growth Potential & Opportunity Outlook 2021” examines the market, competitive landscape and trends of the Global Epilepsy Drug Market. This report analyzes market data and provides a better understanding of Epilepsy Drugs sales value and demand in the Global Market. Market outlook in value terms for the forecasted period for Epilepsy Drugs Market has been detailed in the report. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Epilpesy Drugs Market.
The report concludes with the profiles of major players in the Epilepsy Drugs Market such as UCB, EISAI, Pfizer, Sanofi and Lundbeck. The major market players are evaluated on various parameters such as company overview and latest development and trends in the Epilepsy Drugs Market
Browse full report with TOC @ http://marketreports.biz/report/epilepsy-drugs-market-global-demand-growth-potential-and-market/#
Key Topics Covered in the Report
• Worldwide Epilepsy Drugs Market Analysis (2013 – 2021)
• Worldwide Epilepsy Drugs Market Share (2013 – 2021)
• Worldwide Epilepsy Drugs Brand Market Performance (2013 – 2021)
• Epilepsy Drugs Market – Major Deal Types
• Key Companies Analysis
• Key Drivers and Inhibitors of the Epilepsy Drugs Market
Key Epilepsy Drugs Covered in the Report are as follows:
1. Vimpat(Lacosamide)
2. Keppra(Levetiracetam)
3. Briviact(Brivaracetam)
4. Lamictal(Lamotrigine)
5. Neurontin (Gabapentin)
6. Depakine (Sodium Valproate)
7. Sabril (Vigabatrin)
8. Onfi(Clobazam)
9. Fycompa(Perampanel)
10. Inovelon/Banzel(Rufinamide)
11. Zonegran (Zonisamide)
12. Zebinix (Eslicarbazepine Acetate)
About Us
“MarketReports.biz” offers elevating market research worldwide. We have collection of various syndicated reports of different fields. Customers can buys different reports across various categories such as Chemical and Material, Biotechnology, Healthcare, Food and beverages, Automobile and various sectors. Our Website offers safe and secure online ordering experience, convenient payment options.
Contact Us
Frank Valadez
155 North Wacker Drive, Suite 4250
Chicago, IL 60606
Toll Free: +1-855-918-5551 (USA-CANADA)
Tel: +17739042683
Web: http://marketreports.biz/
Email: sales@marketreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epilepsy Drugs Market 2017- UCB, EISAI, Pfizer here
News-ID: 533177 • Views: …
More Releases from Market Report
Global E-Scooters Market Outlook 2018-2025 : Aodi, Pedego, Elio, IBD, Ford, Jinh …
Global “E-Scooters Market 2018” Industry Share, Growth, Research, Analysis, Development Trends, Demands, and Forecasts.
The Global E-Scooters Market report is crafted by executing an outstanding research process to gather key statistics of the Global E-Scooters Market. The research analysis is based on two sections, particularly, primary research and extensive secondary research. Secondary research includes a practical market review and segmentation of the Global E-Scooters Market. It also highlights important players in…
Digital Patient Monitoring Device Market 2017-2022 Omron Corporation, AT&T Inc, …
Global Digital Patient Monitoring Device Market 2017 Analysis Report audits a Market Regions, Product Categories, with Sales, Business Revenue, Goods cost, Digital Patient Monitoring Device piece of the overall industry and Growth patterns, concentrating on driving Digital Patient Monitoring Device industry players, showcase size, request and supply examination, utilization volume, Forecast 2017 to 2022.
The Global Digital Patient Monitoring Device report gives a thorough situation of the present and gauge Digital…
Pet Food Packaging Market 2017-2022 Amcor Limited, Bemis, Constantia Flexibles, …
Global Pet Food Packaging Market 2017 Analysis Report audits a Market Regions, Product Categories, with Sales, Business Revenue, Goods cost, Pet Food Packaging piece of the overall industry and Growth patterns, concentrating on driving Pet Food Packaging industry players, showcase size, request and supply examination, utilization volume, Forecast 2017 to 2022.
The Global Pet Food Packaging report gives a thorough situation of the present and gauge Pet Food Packaging showcase procedures,…
Chlorinated Polyvinyl Chloride Market 2017-2022 US. Lubrizol, Tokuyama Sekisui J …
Global Chlorinated Polyvinyl Chloride Market 2017 Analysis Report audits a Market Regions, Product Categories, with Sales, Business Revenue, Goods cost, Chlorinated Polyvinyl Chloride piece of the overall industry and Growth patterns, concentrating on driving Chlorinated Polyvinyl Chloride industry players, showcase size, request and supply examination, utilization volume, Forecast 2017 to 2022.
The Global Chlorinated Polyvinyl Chloride report gives a thorough situation of the present and gauge Chlorinated Polyvinyl Chloride showcase procedures,…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
